[1]
“The analysis of the effectiveness and safety of levofloxacin in the treatment of lower respiratory tract infection”, Int Curr Pharm J, vol. 4, no. 12, pp. 462–464, Nov. 2015, doi: 10.3329/icpj.v4i12.25598.